المؤلفون: Colic J; J. Colic, MD, PhDc, Institute of Rheumatology, Belgrade, Serbia; jcolicster@gmail.com., Pruner I; I. Pruner, PhD, Karolinska Institutet, Department of Molecular Medicine and Surgery, Stockholm, Sweden., Damjanov N; N. Damjanov, MD, PhD, M. Sefik-Bukilica, MD, PhD, Institute of Rheumatology, Belgrade, Serbia School of Medicine University of Belgrade, Belgrade, Serbia., Pekmezovic T; T. Pekmezovic, MD, PhD, Institute of Epidemiology, School of Medicine University of Belgrade, Belgrade, Serbia., Sefik-Bukilica M; N. Damjanov, MD, PhD, M. Sefik-Bukilica, MD, PhD, Institute of Rheumatology, Belgrade, Serbia School of Medicine University of Belgrade, Belgrade, Serbia., Antovic A; A. Antovic, MD, PhD, Karolinska Institutet, Department of Medicine Division Solna of Rheumatology, Karolinska University Hospital, Rheumatology, Stockholm, Sweden.

المصدر: The Journal of rheumatology [J Rheumatol] 2022 Jun; Vol. 49 (6), pp. 598-606. Date of Electronic Publication: 2022 Feb 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0315-162X (Print) Linking ISSN: 0315162X NLM ISO Abbreviation: J Rheumatol Subsets: MEDLINE

مواضيع طبية MeSH: Scleroderma, Systemic*/complications , Skin Ulcer*/complications , Thrombosis*, Fibrin ; Fibrin Clot Lysis Time ; Fibrinolysis ; Humans ; Thrombin ; Ulcer

المؤلفون: Pruner I; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.; Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden., Farm M; Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.; Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden., Tomic B; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia., Gvozdenov M; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia., Kovac M; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.; Hemostasis Department, Blood Transfusion Institute of Serbia, Belgrade, Serbia., Miljic P; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.; Clinic of Hematology, University Clinical Center, Belgrade, Serbia., Soutari NMH; Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.; Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden., Antovic A; Department of Medicine, Unit of Rheumatology, Karolinska University Hospital, Stockholm, Sweden.; Academic Specialist Center, Center for Rheumatology, Stockholm Health Services, Stockholm, Sweden., Radojkovic D; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia., Antovic J; Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.; Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden., Djordjevic V; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.

المصدر: Clinical chemistry [Clin Chem] 2020 Feb 01; Vol. 66 (2), pp. 379-389.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9421549 Publication Model: Print Cited Medium: Internet ISSN: 1530-8561 (Electronic) Linking ISSN: 00099147 NLM ISO Abbreviation: Clin Chem Subsets: MEDLINE

مواضيع طبية MeSH: Prothrombin/*genetics , Thrombosis/*genetics, Adult ; Animals ; Blood Coagulation Tests ; COS Cells ; Case-Control Studies ; Chlorocebus aethiops ; Exons/genetics ; Female ; Hemostasis ; Heterozygote ; Humans ; Male ; Mutation ; Phenotype ; Polymorphism, Single Nucleotide/genetics ; Prothrombin/metabolism ; Retrospective Studies ; Risk Factors ; Silent Mutation/genetics ; Thrombin/metabolism ; Thrombophilia/genetics ; Thrombophilia/metabolism ; Thrombosis/metabolism ; Venous Thromboembolism/genetics ; Venous Thromboembolism/metabolism

SCR Disease Name: Hyperprothrombinemia

المؤلفون: Tehrani S; Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Internal Medicine, Stockholm, Sweden. sara.tehrani@ds.se, Mobarrez F, Antovic A, Santesson P, Lins PE, Adamson U, Henriksson P, Wallén NH, Jörneskog G

المصدر: Thrombosis research [Thromb Res] 2010 Sep; Vol. 126 (3), pp. e225-31. Date of Electronic Publication: 2010 Jul 15.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Pergamon Press Country of Publication: United States NLM ID: 0326377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-2472 (Electronic) Linking ISSN: 00493848 NLM ISO Abbreviation: Thromb Res Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 1/*complications , Dyslipidemias/*drug therapy , Fibrinolytic Agents/*therapeutic use , Heptanoic Acids/*therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use , Pyrroles/*therapeutic use , Thrombosis/*drug therapy, Adult ; Aged ; Atorvastatin ; Biomarkers/blood ; Blood Platelets/drug effects ; Blood Platelets/metabolism ; C-Reactive Protein/metabolism ; Cell-Derived Microparticles/drug effects ; Cell-Derived Microparticles/metabolism ; Cross-Over Studies ; Diabetes Mellitus, Type 1/blood ; Double-Blind Method ; Dyslipidemias/blood ; Dyslipidemias/complications ; Fibrin/metabolism ; Glycated Hemoglobin/metabolism ; Humans ; Integrin beta3/blood ; Middle Aged ; P-Selectin/blood ; Plasminogen Activator Inhibitor 1/blood ; Sweden ; Thrombin/metabolism ; Thromboplastin/metabolism ; Thrombosis/blood ; Thrombosis/etiology ; Time Factors ; Treatment Outcome

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.